Commercial Co-pay Program may help make
LEQVIO affordable for eligible patients

Zero dollar icon

Your eligible patients with commercial insurance
may pay as little as $0

No financial information required. Subject to terms and conditions. Limitations apply.*

Enroll your patient in the co-pay program and manage claims for reimbursement in 1 of 2 ways

  • Number one icon
  • Electronically via the Service
    Center Portal (or download our
    1-page Start Form and fax to

    Access to co-pay and all other services in one
    place, including benefits verification, prior
    authorization/appeals support, product
    acquisition, and billing/coding support.

    Visit Service Center Portal
  • Number two icon
  • Electronically via the Co-pay

    Access to co-pay savings, submission for co-
    pay claims, and tracking payment status.

    Visit Co-pay Portal

*Limitations apply. Valid only for those with commercial insurance. The Program may include the Co-pay Card, Payment Card (if applicable), and Rebate. Per treatment maximums and an annual benefit cap apply. For patients covered under the medical benefit, rebate for out-of-pocket costs will be assigned directly to provider, unless patient requests direct reimbursement. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient's insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient's insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.


Expand Collapse


Adverse reactions in clinical trials (≥3% of patients treated with LEQVIO and more frequently than placebo) were injection site reaction, arthralgia, and bronchitis.

Please click here for LEQVIO full Prescribing Information.


LEQVIO (inclisiran) injection is indicated as an adjunct to diet and statin therapy for the treatment of adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce low-density lipoprotein cholesterol (LDL-C).

Please click here for LEQVIO full Prescribing Information.